Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson’s Disease Utilizing LSVT BIG®

Table 4

Primary outcomes and MCID.

ID	Gait Speed; Baseline,; delta post,; delta 3 mths	FGA; Baseline,; delta post,; delta 3 mths	Berg; Baseline,; delta post,; delta 3 mths	UPDRS; Baseline,; delta post,; delta 3 mths	Total MCID; Post,; 3 mths
1	, ,	, ,	, ,	, ,	,
2	, ,	, ,	, ,	, ,	,
3	, ,	, ,	, ,	, ,	,
4	, ,	, ,	, ,	, ,	,
5	, ,	, ,	, ,	, ,	,
6	, ,	, ,	, ,	, ,	,
7	, ,	, ,	, ,	, ,	,
8	, ,	, ,	, ,	, ,	,
9	, ,	, ,	, ,	, ,	,
Total MCID	Post: 4	Post: 3	Post: 4	Post: 7	8 participants achieved MCID in at least 1 measure
	3 mths: 5	3 mths: 3	3 mths: 4	3 mths: 7

Meeting MCID required improvement in performance from baseline.
For Functional Gait Assessment, 2 of 9 participants’ baseline was so high that improvement at a level of MCID was not possible. In fact, participant 8 was at the maximum score possible (=30) at baseline.
For Berg, 4 of 9 participants’ baseline was so high that improvement at a level of MCID was not possible.
For UPDRS, 1 participant’s baseline was so low that improvement at a level of MCID was not possible.
Participant 8 scored well on functional assessments at baseline on the FGA, Berg, andUPDRS, so improvement at a level of MCID was not possible to achieve.